The Indian neurological disorder drugs market is projected to grow at a significant CAGR during the forecast period (2020-2026). The key factors that drive the growth of the market includes the increased prevalence of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and others among the people. The rising geriatric population is another major factor for the market growth in the country. 

As per the journal released by the Deccan Chronicle 2018, it is anticipated that nearly 30 million people in the country suffer from at least any one form of neurological disease and the average prevalence rate is as high as 2,394 patients per 1,00,000 of the population. Such an increased burden of the disease is likely to create a wide scope for market growth as with the increasing burden, the demand for drugs increases. Along with the increased burden of the disease, there is also low awareness regarding the diagnosis and treatment of neurological disorders which may challenge the market growth over the forecast period.

Visit for Global Neurological Disorder Drugs Market Report at: https://www.omrglobal.com/industry-reports/neurological-disorder-drugs-market

The Indian neurological disorder drugs market is segmented on the basis of disorder type into Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, Huntington disease, and others. Amongst the disorder type segment, Parkinson’s disease segment is projected to hold a lucrative share in the market. The segmental growth of the market is attributed to the increased prevalence of Parkinson’s disease among people across the globe. A broad range of drugs is used for the treatment of neurological disorders, some of which include analgesics, antihypertensive, anticholinergic, hypnotic & sedatives, and others. 

Further, Novartis International AG, Pfizer Inc., GlaxoSmithKline Plc, Sun Pharmaceutical Industries Ltd., Cipla Ltd., and Cadila Healthcare Ltd., are some of the prominent players functioning in the global and local players operating in the Indian neurological disorder drugs market. New product launches & developments, partnerships, agreements, and acquisitions are some of the growth strategies adopted by the players in order to sustain in the highly competitive market. 

Research Methodology

The market study of the India neurological disorder drugs market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market
• Whitepapers, research-papers, and news blogs
• Company websites and their product catalog

The reporeport is intended for the pharmaceutical industry, drug manufacturers, hospitals & clinics, research organizations, academic institutes, non-profit organizations, government organizations, regulatory bodies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. India Neurological Disorder Drugs Market Research and Analysis by Disorder Type

The Report Covers:

• Comprehensive research methodology of the Indian Neurological Disorder Drugs market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Indian Neurological Disorder Drugs market.
• Insights about market determinants which are stimulating the Indian Neurological Disorder Drugs market.
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of the market players.